October the 20th 2020 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST),  Crystal Digital PCR™ for Accurate Chimerism Monitoring after Stem Cell Transplantation by Elise Gourri (National Institute of Biology, Slovenia) & Viviane Sternkopf (Stilla Technologies) Speakers’s Bio Elise Gourri, MSc. Scientist Department of Molecular [...]

Stilla Technologies Launches the World’s First Six-Color Digital PCR Instrument Key Applications Include Oncology, Infectious Disease and Food Testing Paris, June 9th, 2020 Stilla Technologies, a leading provider of digital PCR (dPCR) solutions for high-precision genetic analysis, today launched the world’s first six-color digital PCR instrument, the six-color Prism. The instrument expands [...]

Stilla Technologies presents a novel approach for COVID-19 testing combining group testing with digital PCR and publishes the largest comparative study to date for group testing of SARS-CoV-2 The approach significantly reduces costs and increases testing capacity while offering a diagnostic sensitivity greater than the current standard of individual RT-PCR tests Paris, June 5th, [...]

Watch our June online seminars and learn More about our new 6-color digital PCR system and its set of applications! Speakers Topics Date Innovation in Digital PCR: Maximizing Data Output from Precious Samples Features of our new 6-color dPCR System Set of applications poised [...]

June the 11th 2020 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST),  Innovation in Digital PCR: Maximizing Data Output from Precious Samples by Alexandra Bogožalec Košir (National Institute of Biology, Slovenia) & Allison Mallory (Stilla Technologies) Speakers’s Bio Alexandra Bogožalec Košir Research Assistant National Institute [...]

Stilla Technologies offers a digital PCR solution to detect Covid-19 infections more sensitively and more accurately than the current RT-PCR method The Naica™ system, Stilla Technologies’ innovative digital PCR solution, combined with a Covid-19 detection kit, is able to quickly, accurately and reliably identify the SARS-CoV-2 virus, which is responsible for Covid-19, as well as [...]

May the 20th 2020 - (10:20 AM PDT | 1:20 PM EDT | 6:20 PM BST | 7:20 PM CEST),  Highly Sensitive Crystal Digital PCRTM Detection kit for SARS-CoV-2 by Romain Parillaud, PhD (Stilla Technologies) Speakers’s Bio Romain received his PhD in Neuro-Immunology at Paris VI University, using gene expression analysis on [...]

Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China.  A Franco‐Chinese collaboration to better detect the virus and monitor its mutations Paris, February 25th, 2020 Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high‐precision genetic analyses, just announced it [...]

Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones.  Paris, February 11th, 2020 Stilla Technologies announced today that it has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group [...]

February the 27th 2020 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST),  Digital PCR Method Development for Accurate Quantification of Copy Number Variations by Alexandra Whale (LGC London) Speakers’s Bio Alexandra Whale is the Science Leader for Nucleic Acid Innovation within the Molecular and [...]